← SynDRA
OLUTASIDENIB
SynDRA canonical compound SYN0039706 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | IDH1 |
| Mechanism of action | isocitrate dehydrogenase inhibitor |
| Indication | glioma |
| Disease area | oncology |
All known targets
Mechanisms of action (all sources)
- IDH1 INHIBITOR
- Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor
- isocitrate dehydrogenase inhibitor
Drug classes
ATC classes
- L01X · OTHER ANTINEOPLASTIC AGENTS
Cross-references
Synonyms
- rezlidhia
- FT-2102
- Rezlidhia
- NEQYWYXGTJDAKR-JTQLQIEISA-N
- UNII-0T4IMT8S5Z
- 0T4IMT8S5Z
- (S)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile
- Olutasidenib [USAN]
- SCHEMBL17603134
- HY-114226
- CS-0080183
- 5-(((1S)-1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile
- 2-Pyridinecarbonitrile, 5-(((1S)-1-(6-chloro-1,2-dihydro-2-oxo-3-quinolinyl)ethyl)amino)-1,6-dihydro-1-methyl-6-oxo-
- FT 2102
- olutasidenibum
- RefChem:57416
- IDH1-R132 Inhibitor FT-2102
- Olutasidenib (FT-2102)
- FT2102
- Rezlidhia (TN)
- OLUTASIDENIB [INN]
- Olutasidenib (FT-2102)?
- OLUTASIDENIB [WHO-DD]
- Olutasidenib (JAN/USAN/INN)
- orb1307932
- SCHEMBL29373022
- GTPL10319
- GLXC-07714
- HMS6018C12
- EX-A4523
- ARD193797
- BDBM50506474
- example 26 [US9834539B2]
- NSC818621
- s8949
- AKOS040742332
- NSC-818621
- EBC-2669075
Look up OLUTASIDENIB in the interactive SynDRA portal →